Quantum Biopharma Ltd
(QNTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 5,968 | 16,306 | N/A | N/A |
| Receivables | 1,557 | 758 | N/A | N/A |
| Inventories | 709 | N/A | N/A | N/A |
| TOTAL | $8,558 | $17,413 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 8,880 | 9,367 | N/A | N/A |
| Investments And Advances | 8,863 | 13,937 | 0 | 0 |
| Intangibles | 16,821 | 0 | 0 | 0 |
| Other Non-Current Assets | 96 | 0 | 0 | 0 |
| TOTAL | $34,660 | $23,304 | $N/A | $N/A |
| Total Assets | $43,218 | $40,717 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,361 | 1,345 | 0 | 0 |
| Other current liabilities | 1,991 | N/A | N/A | N/A |
| TOTAL | $6,830 | $1,345 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 110 | 0 | 0 | 0 |
| TOTAL | $110 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,940 | $1,345 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 73,738 | 52,553 | N/A | N/A |
| Retained earnings | -59,069 | -20,449 | N/A | N/A |
| Other shareholders' equity | 4,237 | 3,427 | 0 | 0 |
| TOTAL | $36,278 | $39,372 | $N/A | $N/A |
| Total Liabilities And Equity | $43,218 | $40,717 | $0 | $0 |